IMI2-2015-04-01 - Enabling Platform on Medicines Adaptive Pathways to Patients
Activities generated from the priority areas under IMI2 will be designed considering relevant differentiating enablers for early and effective patient access to innovative prevention and treatment solutions (Medicines Adaptive Pathway to Patients-MAPPs). However a pre-requisite for the success of MAPPs implementation lies in full and common understanding of its value for all relevant stakeholders
Support is therefore required to bring together relevant stakeholders to foster discussion and coordinate activities under IMI2 to progress innovative, pragmatic and viable solutions required to implement MAPPs
Establishment of an enabling platform with relevant stakeholders for the coordination of MAPPs related activities within IMI2. This forum will enable a gap analysis, informing new research activities in IMI2 and creating a comprehensive repository of knowledge of activities including non IMI activities relevant to MAPPs and opportunities for coordination.
Comprehensive plan of development and exploitation of tools, methodologies, infrastructures that will allow changes in R&D, regulatory and medical practice to enable early patient access to innovative prevention and treatment options.
IMI contribution: EUR 1 130 000
EFPIA contribution: EUR 1 130 000
Total: EUR 2 260 000